专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

61. 外观设计

USD368903S IC module 失效
公开(公告)号：USD368903S
公开(公告)日：1996-04-16
申请号：US36254
申请日：1995-03-16
申请人： Jun Ohmori , Hiroshi Iwasaki
设计人： Jun Ohmori , Hiroshi Iwasaki

62. 发明授权

US5148244A Enhancement-FET and depletion-FET with different gate length formed in compound semiconductor substrate 失效
标题翻译：在化合物半导体衬底中形成的具有不同栅极长度的增强型FET和漏极FET
公开(公告)号：US5148244A
公开(公告)日：1992-09-15
申请号：US653294
申请日：1991-02-11
申请人： Hiroshi Iwasaki
发明人： Hiroshi Iwasaki
IPC分类号： H01L27/088 , H01L21/8236 , H01L27/095 , H03K19/0944
CPC分类号： H01L27/095
摘要： This invention provides an E/D integrated circuit obtained by connecting an enhancement transistor serving as a switching transistor to a depletion transistor serving as a load and having a gate length larger than a gate length of the enhancement transistor in series with each other.

63. 发明授权

US5137891A 2',3' cyclic fused pyrazolopyrimidine type mevalonolactones 失效
标题翻译： 2'，3'环稠合吡唑并嘧啶型甲羟戊酸内酯
公开(公告)号：US5137891A
公开(公告)日：1992-08-11
申请号：US715456
申请日：1991-06-14
申请人： Yoshihiro Fujikawa , Mikio Suzuki , Hiroshi Iwasaki , Mitsuaki Sakashita , Masaki Kitahara
发明人： Yoshihiro Fujikawa , Mikio Suzuki , Hiroshi Iwasaki , Mitsuaki Sakashita , Masaki Kitahara
IPC分类号： A61K31/505 , A61P3/06 , A61P9/10 , A61P43/00 , C07D487/04
CPC分类号： C07D487/04
摘要： The present invention provides a compound of the formula: ##STR1## process for their production, pharmaceutical compositions containing them and their pharmaceutical uses, and intermediates useful for their production and processes for the production of such intermediates.
摘要翻译：本发明提供下式的化合物：其制备方法，含有它们的药物组合物及其药物用途，以及可用于其生产的中间体和用于生产这种中间体的方法。

64. 发明授权

US5102888A Quinoline type mevalonolactones useful for treating hyperlipidemia and related diseases 失效
标题翻译：适用于治疗高脂血症和相关疾病的喹诺酮类型的美洛酮
公开(公告)号：US5102888A
公开(公告)日：1992-04-07
申请号：US483724
申请日：1990-02-23
申请人： Yoshihiro Fujikawa , Mikio Suzuki , Hiroshi Iwasaki , Mitsuaki Sakashita , Masaki Kitahara
发明人： Yoshihiro Fujikawa , Mikio Suzuki , Hiroshi Iwasaki , Mitsuaki Sakashita , Masaki Kitahara
IPC分类号： A61K31/47 , A61K31/473 , A61P3/06 , A61P7/00 , A61P9/10 , C07D215/12 , C07D215/14 , C07D215/18 , C07D215/20 , C07D215/38 , C07D215/54 , C07D221/06 , C07D405/06 , C07D491/056
CPC分类号： C07D405/06 , C07D215/14 , C07D215/18 , C07D215/20
摘要： A compound of the formula: ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.6 are independently hydrogen, C.sub.1-6 alkyl, C.sub.1-6 cycloalkyl, C.sub.1-3 alkoxy, n-botoxy, i-botoxy, sec-butoxy, R.sup.7 R.sup.8 N-- (wherein R.sup.7 and R.sup.8 are independently hydrogen or C.sub.1-3 alkyl), trifluoromethyl, trifluoromethoxy, difluoromethoxy, fluoro, chloro, bromo, phenyl, phenoxy, benzyloxy, hydroxy, trimethylsilyloxy, diphenyl-t-butylsilyloxy, hydroxymethyl or --O(CH.sub.2).sub.l OR.sup.19 (wherein R.sup.19 is hydrogen or C.sub.1-3 alkyl, and l is 1,2 or 3); or when located at the ortho position to each other, R.sup.1 and R.sup.2, or R.sup.3 and R.sup.4 together form --CH.dbd.CH--CH.dbd.CH--; or when located at the ortho position to each other, R.sup.1 and R.sup.2 together form --OC(R.sup.15) (R.sup.16)O--(wherein R.sup.15 and R.sup.16 are independently hydrogen or C.sub.1-3 alkyl); Y is --CH.sub.2 --, --CH.sub.2 CH.sub.2 --, --CH.dbd.CH--, --CH.sub.2 --CH.dbd.CH-- or -- CH.dbd.CH--CH.sub.2 --; and Z is --Q--CH.sub.2 WCH.sub.2 --CO.sub.2 R.sup.12, ##STR2## (wherein Q is --C(O)--, --C(OR.sup.13).sub.2 -- or --CH(OH)--; W is --C(O)--, --C(OR.sup.13).sub.2 -- or --C(R.sup.11) (OH)--; R.sup.11 is hydrogen atom or C.sub.1-3 alkyl; R.sup.12 is hydrogen or R.sup.14 (wherein R.sup.14 is physiologically hydrolyzable alkyl or M (wherein M is NH.sub.4, sodium, potassium, 1/2 calcium or a hydrate of lower alkyl amine, di-lower alkyl amine or tri-lower alkyl amine)); two R.sup.13 are independently primary or secondary C.sub.1-6 alkyl; or two R.sup.13 together form --(CH.sub.2).sub.2 -- or --(CH.sub.2).sub.3 ; R.sup.17 and R.sup.18 are independently hydrogen or C.sub.1-3 alkyl; and R.sup.5 is hydrogen, C.sub.1-6 alkyl, C.sub.2-3 alkenyl, C.sub.3-6 cycloalkyl, ##STR3## wherein R.sup.9 is a hydrogen atom, C.sub.1-4 alkyl, C.sub.1-3 alkoxy, fluoro, chloro, bromo or trifluoromethyl), phenyl-(CH.sub.2).sub.m -- (wherein m is 1,2 or 3), --(CH.sub.2).sub.n CH(CH.sub.3)--phenyl or phenyl--(CH.sub.2).sub.n CH(CH.sub.3)-- (wherein n is 0,1 or 2).

65. 发明授权

US5011930A Quinoline type mevalonolactones 失效
标题翻译：喹啉型甲羟戊酸内酯
公开(公告)号：US5011930A
公开(公告)日：1991-04-30
申请号：US483720
申请日：1990-02-23
申请人： Yoshihiro Fujikawa , Mikio Suzuki , Hiroshi Iwasaki , Mitsuaki Sakashita , Masaki Kitahara
发明人： Yoshihiro Fujikawa , Mikio Suzuki , Hiroshi Iwasaki , Mitsuaki Sakashita , Masaki Kitahara
IPC分类号： A61K31/47 , A61K31/473 , A61P3/06 , A61P7/00 , A61P9/10 , C07D215/12 , C07D215/14 , C07D215/18 , C07D215/20 , C07D215/38 , C07D215/54 , C07D221/06 , C07D405/06 , C07D491/056
CPC分类号： C07D405/06 , C07D215/14 , C07D215/18 , C07D215/20
摘要： A compound of the formula: ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.6 are independently hydrogen, C.sub.1-6 alkyl, C.sub.1-6 cycloalkyl, C.sub.1-3 alkoxy, n-botoxy, i-botoxy, sec-butoxy, R.sup.7 R.sup.8 N-- (wherein R.sup.7 and R.sup.8 are independently hydrogen or C.sub.1-3 alkyl), trifluoromethyl, trifluoromethoxy, difluoromethoxy, fluoro, chloro, bromo, phenyl, phenoxy, benzyloxy, hydroxy, trimethylsilyloxy, diphenyl-t-butylsilyloxy, hydroxymethyl or --O(CH.sub.2).sub.l OR.sup.19 (wherein R.sup.19 is hydrogen or C.sub.1-3 alkyl, and l is 1,2 or 3); or when located at the ortho position to each other, R.sup.1 and R.sup.2, and R.sup.3 and R.sup.4 together form --CH.dbd.CH--CH.dbd.CH--; or when located at the ortho position to each other, R.sup.1 and R.sup.2 together form --OC(R.sup.15)(R.sup.16)O-- (wherein R.sup.15 and R.sup.16 are independently hydrogen or C.sub.1-3 alkyl); Y is --CH.sub.2 --, --CH.sub.2 CH.sub.2 --, --CH.dbd.CH--, --CH.sub.2 CH.dbd.CH-- or --CH.dbd.CH-- CH.sub.2 --; and Z is --Q--CH.sub.2 WCH.sub.2 --CO.sub.2 R.sup.12, ##STR2## (wherein Q is --C(O)--, --C(OR.sup.13).sub.2 -- or --CH(OH)--; W is --C(O)--, --C(OR.sup.13).sub.2 -- or --C(R.sup.11)(OH)--; R.sup.11 is hydrogen atom or C.sub.1-3 alkyl; R.sup.12 is hydrogen or R.sup.14 (wherein R.sup.14 is physiologically hydrolyzable alkyl or M (wherein M is NH.sub.4, sodium, potassium, 1/2 calcium or a hydrate of lower alkyl amine, di-lower alkyl amine or tri-lower alkyl amine)); two R.sup.13 are independently primary or secondary C.sub.1-6 alkyl; or two R.sup.13 together form --(CH.sub.2).sub.2 -- or --(CH.sub.2).sub.3 ; R.sup.17 and R.sup.18 are independently hydrogen or C.sub.1-3 alkyl; and R.sup.5 is hydrogen, C.sub.1-6 alkyl, C.sub.2-3 alkenyl, C.sub.3-6 cycloalkyl, ##STR3## (wherein R.sup.9 is a hydrogen atom, C.sub.1-4 alkyl, C.sub.1-3 alkoxy, fluoro, chloro, bromo or trifluoromethyl), phenyl-(CH.sub.2).sub.m -- (wherein m is 1,2 or 3), --(CH.sub.2).sub.n CH(CH.sub.3)-phenyl or phenyl-(CH.sub.2).sub.n CH(CH.sub.3)-- (wherein n is 0,1 or 2).
摘要翻译：下式的化合物：其中R 1，R 2，R 3，R 4和R 6独立地是氢，C 1-6烷基，C 1-6环烷基，C 1-3烷氧基，正丁氧基，异丁氧基，仲丁氧基，丁氧基，R7R8N-（其中R7和R8独立地是氢或C1-3烷基），三氟甲基，三氟甲氧基，二氟甲氧基，氟，氯，溴，苯基，苯氧基，苄氧基，羟基，三甲基甲硅烷氧基，二苯基叔丁基甲硅烷氧基，羟甲基或 - O（CH 2）lOR 19（其中R 19是氢或C 1-3烷基，且l是1,2或3）; 或当位于彼此的邻位时，R1和R2以及R3和R4一起形成-CH = CH-CH = CH-; 或者当位于彼此的邻位时，R 1和R 2一起形成-OC（R 15）（R 16）O-（其中R 15和R 16独立地是氢或C 1-3烷基）; Y是-CH 2 - ， - CH 2 CH 2 - ， - CH = CH - ， - CH 2 CH = CH-或-CH = CH-CH 2 - ; （其中Q为-C（O） - ， - C（OR 13）2 - 或-CH（OH） - ）; W为-C（O） - （CH 2），-C（OR 13）2 - 或-C（R 11）（OH） - ; R 11为氢原子或C 1-3烷基; R 12为氢或R 14（其中R 14为生理上可水解的烷基或M（其中M为NH 4，钠，二价低级烷基胺或三低级烷基胺的水合物））;两个R 13独立地为伯或仲C 1-6烷基;或两个R 13一起形成 - （CH 2） 2-或 - （CH 2）3; R 17和R 18独立地是氢或C 1-3烷基;且R 5是氢，C 1-6烷基，C 2-3烯基，C 3-6环烷基，其中R 9是氢苯基 - （CH 2）m - （其中m为1,2或3）， - （CH 2）n CH（CH 3） - 苯基或（C 1 -C 4）烷基，C 1-4烷氧基，氟，氯，溴或三氟甲基）苯基 - （CH 2）n CH（CH 3） - （其中n为0,1或2）。

66. 发明授权

US4977161A Isoxazolopyridine type mevalonolactones 失效
标题翻译：异恶唑吡啶型甲羟戊酸内酯
公开(公告)号：US4977161A
公开(公告)日：1990-12-11
申请号：US434254
申请日：1989-11-13
申请人： Yoshihiro Fujikawa , Mikio Suzuki , Hiroshi Iwasaki , Mitsuaki Sakashita , Masaki Kitahara
发明人： Yoshihiro Fujikawa , Mikio Suzuki , Hiroshi Iwasaki , Mitsuaki Sakashita , Masaki Kitahara
IPC分类号： A61K31/445 , A61P3/08 , A61P9/10 , C07D498/04
CPC分类号： C07D498/04
摘要： The present invention provides a compound of the formula: ##STR1## process for their production, pharmaceutical compositions containing them and their pharmaceutical uses, and intermediates useful for their production and processes for the production of such intermediates. The compounds are used as anti-hyperlipoproteinemic agents for example.

67. 发明授权

US4774556A Non-volatile semiconductor memory device 失效
标题翻译：非易失性半导体存储器件
公开(公告)号：US4774556A
公开(公告)日：1988-09-27
申请号：US887625
申请日：1986-07-21
申请人： Tetsuo Fujii , Nobuyoshi Sakakibara , Toshio Sakakibara , Hiroshi Iwasaki
发明人： Tetsuo Fujii , Nobuyoshi Sakakibara , Toshio Sakakibara , Hiroshi Iwasaki
IPC分类号： H01L21/28 , H01L21/336 , H01L21/8246 , H01L21/8247 , H01L27/115 , H01L29/423 , H01L29/788 , H01L29/78 , H01L29/86
CPC分类号： H01L27/11568 , H01L21/28273 , H01L27/11556 , H01L29/66825 , H01L29/7881 , H01L29/7883 , H01L27/115 , H01L29/4236
摘要： A non-volatile semiconductor memory device comprises a semiconductor substrate of a first conduction type, an impurity buried layer of a second conduction type formed at the surface of the semiconductor substrate for constituting either one of a drain region or a source region, an epitaxial layer of a second conduction type formed at the surface of said impurity buried layer, an insulatiang partition wall extended vertically from the surface of the epitaxial layer surrounding operation regions in the impurity buried layer for defining the operation regions therein, at least one electron holding portion extended vertically with a predetermined distance from the operation regions and disposed within the insulating partition wall apart from the operation region, the impurity buried layer or the drain region by an insulation film of such a thickness as causing a tunnel effect, control gates disposed within the insulation partition wall disposed on every electron holding portions on the side opposite to the operation regions and extended vertically with a certain gap from the electron maintaining portions, and a control gate disposed within the insulating partition wall on every electron holding portions on the opposite side to the operation region extended vertically and with a certain gap to the electron holding portions, and an impurity region of a second conduction type formed at the surface of the operation region for constituting the other of the drain region or the source region.
摘要翻译：非易失性半导体存储器件包括：第一导电类型的半导体衬底，形成在半导体衬底的表面的第二导电类型的杂质掩埋层，用于构成漏极区域或源极区域中的任一个，外延层形成在所述杂质掩埋层的表面上的第二导电类型的绝缘分隔壁，包围在所述杂质掩埋层中的围绕所述杂质掩埋层的操作区域的外延层的表面垂直延伸的绝缘隔壁，用于限定其中的操作区域，至少一个电子保持部分延伸垂直于操作区域预定的距离并且设置在与操作区域隔离的绝缘分隔壁内，通过具有隧道效应的厚度的绝缘膜的杂质掩埋层或漏极区域，设置在绝缘体内的控制栅极分隔壁设置在侧面上的每个电子保持部分上 e与操作区域相对并且与电子维持部分具有一定间隙垂直延伸;以及控制栅极，设置在绝缘分隔壁内的每个电子保持部分上，与操作区域相对的一侧垂直延伸并且具有一定间隙电子保持部分和形成在用于构成漏极区域或源极区域中的另一个的操作区域的表面处的第二导电类型的杂质区域。

68. 发明授权

US4694562A Method for manufacturing a semiconductor integrated device including bipolar and CMOS transistors 失效
标题翻译：用于制造包括双极和CMOS晶体管的半导体集成器件的方法
公开(公告)号：US4694562A
公开(公告)日：1987-09-22
申请号：US925266
申请日：1986-10-31
申请人： Hiroshi Iwasaki , Shintaro Ito
发明人： Hiroshi Iwasaki , Shintaro Ito
IPC分类号： H01L21/8249 , H01L21/38
CPC分类号： H01L21/8249
摘要： A semiconductor integrated device (CBi-CMOS) is disclosed wherein both CMOS transistors and a vertical npn and pnp transistor are formed in a single semiconductor substrate and a latch up phenomenon in the CMOS is prevented. A method of manufacturing the CBi-CMOS is also disclosed. In the CBi-CMOS, four elements, that is, an n-MOSFET, a p-MOSFET and npn and pnp vertical transistors are formed in an n-type epitaxial silicon layer formed on a p-type silicon substrate. The n-MOSFET is formed in a p-well which has a p.sup.+ -type buried region. In the element region of the p-MOSFET, an n.sup.+ -type buried region is also formed. In the element regions of the npn and pnp vertical transistors, a first p.sup.+ -type isolation diffusion region is selectively formed. And an n.sup.+ -type buried region is selectively formed both in these element region of the npn and pnp vertical transistors. In the element region of the npn transistor, the vertical npn transistor is formed using the n-type region surrounded by the first p.sup.+ -type isolation diffusion region as a collector. In the element region of the pnp transistor, a p.sup.+ -type buried region is formed on the n.sup.+ -type buried region, and the vertical pnp transistor is formed using the p.sup.+ -type buried region as a collector. In this case, a second p.sup.+ -type isolation diffusion region is formed to isolate an n-type base region of the vertical pnp transistor.
摘要翻译：公开了一种半导体集成器件（CBi-CMOS），其中在单个半导体衬底中形成CMOS晶体管和垂直npn和pnp晶体管，并且防止了CMOS中的闭锁现象。还公开了制造CBi-CMOS的方法。在CBi-CMOS中，在p型硅衬底上形成的n型外延硅层中形成四个元件，即n-MOSFET，p-MOSFET和npn和pnp垂直晶体管。 n-MOSFET形成在具有p +型掩埋区的p阱中。在p-MOSFET的元件区域中，也形成n +型掩埋区域。在npn和pnp垂直晶体管的元件区域中，选择性地形成第一p +型隔离扩散区域。并且在npn和pnp垂直晶体管的这些元件区域中选择性地形成n +型掩埋区域。在npn晶体管的元件区域中，使用由第一p +型隔离扩散区域包围的n型区域作为集电极形成垂直npn晶体管。在pnp晶体管的元件区域中，在n +型掩埋区域上形成p +型掩埋区域，使用p +型掩埋区域作为集电体形成垂直pnp晶体管。在这种情况下，形成第二p +型隔离扩散区，以隔离垂直pnp晶体管的n型基极区。

69. 发明授权

US4349454A Preparation of aqueous medium suitable for preparing microcapsules 失效
标题翻译：适用于制备微胶囊的水性介质的制备
公开(公告)号：US4349454A
公开(公告)日：1982-09-14
申请号：US115915
申请日：1980-01-28
申请人： Hiroshi Iwasaki , Shinsuke Irii , Mitsuru Kondo
发明人： Hiroshi Iwasaki , Shinsuke Irii , Mitsuru Kondo
IPC分类号： B41M5/136 , B41M5/165 , C09B11/02 , B01J13/00 , B01J13/02
CPC分类号： C09B11/02 , B41M5/136 , B41M5/1655 , Y10S428/914
摘要： A hydrophobic organic solvent containing a compound of the formula ##STR1## is dispersed and emulsified in an aqueous medium containing a sulfinic acid of the formulaR.sub.5 --SO.sub.2 H (I)and serving as an aqueous medium for preparing microcapsules to react the compounds of the formulae (I) and (II) and synthesize a diarylmethane derivative of the formula ##STR2## while encapsulating oily droplets of the resulting hydrophobic organic solvent solution of the diarylmethane derivative. Colorless chromogenic materials can be synthesized and encapsulated at the same time by this process.
摘要翻译：将含有式（II）化合物的疏水性有机溶剂分散并乳化在含有式R 5 -SO 2 H（I）的亚磺酸的水性介质中，并用作制备微胶囊以使化合物的式（I）和（II）的化合物，并合成式（III）的二芳基甲烷衍生物，同时包封所得的二芳基甲烷衍生物的疏水性有机溶剂溶液的油滴。无色发色材料可以通过该方法同时合成和包封。

70. 发明授权

US4266081A Process for preparation of peroxides 失效
标题翻译：过氧化物的制备方法
公开(公告)号：US4266081A
公开(公告)日：1981-05-05
申请号：US944271
申请日：1978-09-21
申请人： Kenichi Mizuno , Hiroshi Iwasaki , Hirohiko Nambu
发明人： Kenichi Mizuno , Hiroshi Iwasaki , Hirohiko Nambu
IPC分类号： C07B61/00 , B01J27/00 , C07C67/00 , C07C407/00 , C07C409/16 , C07C179/093 , C07C179/06
CPC分类号： C07C409/16 , C07C407/00 , C07C407/003
摘要： A process for the preparation of peroxides by condensation reaction of a tertiary organic hydroperoxide with a tertiary alcohol, which is characterized in that zinc chloride is present as a catalyst in an amount of at least 1% by weight based on the tertiary alcohol, is disclosed. This process can be advantageously applied to continuous manufacture of peroxides, and according to this process, peroxides can be obtained in high yields.
摘要翻译：公开了通过叔有机氢过氧化物与叔醇的缩合反应来制备过氧化物的方法，其特征在于氯化锌作为催化剂以基于叔醇为至少1重量％的量存在。。该方法可以有利地应用于过氧化物的连续制造，并且根据该方法，可以高产率获得过氧化物。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式